NCT02016053

Brief Summary

500 patients with normal renal function will be prospectively studied and incidence, spectrum and natural history of AKI (Acute Kidney Injury) will be observed in them and in 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied for 1 year. Also biomarkers will be studied and validated as early predictors of AKI (Acute Kidney Injury).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 19, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

August 13, 2015

Status Verified

November 1, 2014

Enrollment Period

1.4 years

First QC Date

December 9, 2013

Last Update Submit

August 11, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence , spectrum and natural history of Acute Kidney Injury in patients with cirrhosis

    Incidence is defined as No. of AKI (Acute Kidney Injury) patients during the follow up period of 1 year. Spectrum is defined as Grading of AKIN (Acute Kidney Injury Network) 1,2,3 in different child status (Child A,Child B and Child C) at the end . Natural History is defined as Occurrence of AKI (Acute Kidney Injury) and its recovery during the follow up period of 1 year.

    1 Year

Secondary Outcomes (2)

  • To study predictive value of Cystatin C in comparison to serum creatinine as early predictor of development and outcome of AKI in a cohort of Cirrhotics.

    1 Years

  • To study predictive value of Cystatin C to determine progression or resolution of Acute Kidney Injury

    1 Years

Study Arms (2)

cirrhosis with baseline renal function

500 patients of cirrhosis with normal baseline renal function will be enrolled.

Cirrhosis with Acute Kidney Injury (AKI).

Cirrhotics patients who present with AKI (Acute Kidney Injury) will be enrolled.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

500 patients with normal renal function. 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied.

You may qualify if:

  • \- Group A: 500 patients of cirrhosis with normal baseline renal function will be enrolled Group B : 200 patients who present with AKI (Acute Kidney Injury) will be enrolled

You may not qualify if:

  • Age \< 18 or \> 70 years
  • Preexisting Chronic Renal Disease
  • Patients with obstructive uropathy.
  • Cirrhosis with HCC (HepatoCellular Carcinoma).
  • Advanced cardiopulmonary disease
  • Pregnancy
  • Patients with extrahepatic malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Liver & Biliary Sciences

New Delhi, National Capital Territory of Delhi, 110070, India

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2013

First Posted

December 19, 2013

Study Start

December 1, 2013

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

August 13, 2015

Record last verified: 2014-11

Locations